From Lab to Home: Ultrasensitive Rapid Detection of SARS-CoV-2 with a Cascade CRISPR/Cas13a-Cas12a System Based Lateral Flow Assay-Reference-Cited by-同舟云学术

From Lab to Home: Ultrasensitive Rapid Detection of SARS-CoV-2 with a Cascade CRISPR/Cas13a-Cas12a System Based Lateral Flow Assay

Published:2024-08-20 Issue:35 Volume:96 Page:14197-14204
ISSN:0003-2700
Container-title:Analytical Chemistry
language:en
Short-container-title:Anal. Chem.

Author:

Hu Ronghuan¹²,Guo Chuanghao¹²,Liu Conghui¹²,Zhang Qianling³^ORCID,Zhang Xueji¹²^ORCID,Chen Yong¹³,Liu Yizhen¹²^ORCID

Affiliation:

1. Research Center for Nanosensor Molecular Diagnostic & Treatment Technology, College of Chemistry and Environmental Engineering, Shenzhen University, Shenzhen 518060, Guangdong, People’s Republic of China

2. Shenzhen Key Laboratory of Nano-Biosensing Technology, Shenzhen 518060, Guangdong, People’s Republic of China

3. Environmental Engineering and Graphene Composite, Research Center, College of Chemistry and Environmental, Engineering, Shenzhen University, Shenzhen 518060, Guangdong, People’s Republic of China

Funder

Shenzhen Science and Technology Innovation Commission

National Natural Science Foundation of China

Natural Science Foundation of Guangdong Province

Special Foundation for State Major Research Program of China

Publisher

American Chemical Society (ACS)

Link

https://pubs.acs.org/doi/pdf/10.1021/acs.analchem.4c02726

Reference30 articles.

1. COVID-19 Point-of-Care Diagnostics: Present and Future

2. Simplified Cas13-based assays for the fast identification of SARS-CoV-2 and its variants

3. A CRISPR-based assay for the detection of opportunistic infections post-transplantation and for the monitoring of transplant rejection

4. Rapid deep learning-assisted predictive diagnostics for point-of-care testing

5. COVID-19: a gray swan’s impact on the adoption of novel medical technologies